LAST PRICE - AT THE CLOSE
EMRAF is DOWN -9% since the begininning of the year
EMRAF is DOWN -3% BELOW 20 day SMA
EMRAF is DOWN -3% BELOW 200 day SMA
PROFITABLE: YES
EPS: $0.5382
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: 20.9945
INCOME TO DEBT RATIO: 0.03
 |
THE STOCK IS 34.4% AWAY FROM ALL-TIME HIGHS OF $52.56 |
 |
EMRAF IS DOWN -9% SINCE THE BEGINNING OF THE YEAR |
 |
EMRAF IS DOWN -17% OVER THE PAST 12 MONTHS |
 |
EMRAF IS DOWN -1% OVER THE PAST 1 MONTH |
 |
1% OF ALL EMRAF INVESTORS ARE BETTING AGAINST EMRAF |
 |
NUM INVESTORS SHORT EMRAF HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|
 |
EMRAF moved up 0 in the previous minute |
 |
EMRAF is up 0.35 over the last hour |
 |
EMRAF is up 1% over the last 5 days |
 |
EMRAF is 0.4 above its 8 day SMA |
| $34.19 |   DAY |
$34.50 |
| $34.74 | PREVIOUS DAY |
$34.74 |
| $34.62 |  WEEK |
$35.10 |
| $33.48 | MONTH |
$37.38 |
| $31.85 | YEAR |
$43.89 |
EMRAF is mentioned N/A less than normal on 
EMRAF is mentioned N/A times in an average day on 
